Search by Keyword
Cooper v. Takeda Jury Presented with Plaintiff Closing Argument Linking Actos and Bladder Cancer
Takeda Pharmaceuticals, the Japanese pharmaceutical giant responsible for the development and marketing of the diabetes drug Actos, concealed the association between Actos and bladder cancer, a jury was recently told in an Actos trial. ccording to a Bloomberg Businessweek report on the Actos trial being heard in Los Angeles, as early as 2004, Takeda knew about the associated between Actos and bladder cancer. Furthermore, with this awareness, the Japanese pharmaceutical company failed to inform the U.S. Food and Drug Administration (FDA), according to the plaintiffs lawyer in the case, Continue Reading
Bayer Loses Yaz Patent in Federal Court of Appeals: Generic Yaz Versions Begin (Stealing) Marketshare
Bayer was recently dealt a setback in a Federal Court of Appeals in Washington. Their patent on Yaz, a contraceptive pill, was deemed to no longer be worthy of patent protection. Bayer’s patent on Yaz expires in June 2014. As a result of this ruling, Actavis Inc. and Novartis AG can sell generic versions of the birth control pill. Though the ruling now gives other pharmaceutical companies the ability to legally compete against Bayer in the drospirenone contraceptive pill market, generic and inexpensive versions of Yaz-like drugs are driving Continue Reading
Carey Danis & Lowe Pradaxa Lawyers Currently Following Pradaxa MDL 2385
Carey Danis & Lowe Pradaxa lawyers are currently following the Pradaxa multi-district litigation (MDL) in Illinois. The Pradaxa MDL is In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation MDL no. 2385. The Pradaxa MDL is being heard in the U.S. District Court for the Southern District of Illinois, and is presided over by Chief Judge David R. Herndon. According to Carey Danis & Lowe Pradaxa lawyers, the Pradaxa MDL 2385 continues to move forward with pre-trial proceedings. As documented in minutes from the latest Pradaxa MDL status conference, the Continue Reading
FDA Approves New Anticoagulation Reversal Agent and Boehringer Ingelheim Updates Pradaxa Label
The U.S. Food and Drug Administration (FDA) recently approved a reversal agent to be used in patients experiencing serious and uncontrollable bleeding. The anticoagulation reversal agent is called Kcentra, a product developed and manufactured by CSL Behring. The new treatment counteracts the effects of vitamin K antagonist (VKA) anticoagulation, which could be triggered by the use of an anticoagulant medicine such as Pradaxa or warfarin. The advantage of Kcentra is healthcare providers do not have to thaw the reversal agent, as they commonly do with plasma treatments, nor do Continue Reading
Carey Danis & Lowe Actos Cancer Lawyers Optimistic Following Cooper v. Takeda $6.5 Million Compensatory Award
A California jury recently awarded a compensatory package of $6.5 million to a plaintiff in an Actos bladder cancer lawsuit. The case, Cooper v. Takeda, was heard over a two month period in a California Superior Court. The jury arrived at their decision agreeing with Cooper’s claim that Takeda Pharmaceuticals, the manufacturer of the diabetes drug Actos, did not supply adequate safety information about the association between Actos and bladder cancer. The plaintiff in the case, Jack Cooper, was presented with a $5 million compensatory award. The jury also Continue Reading
Carey Danis & Lowe Pelvic Mesh Lawyers Weigh in on Ethicon MDL 2327 and Gynecare Prolift Mesh Lawsuit Removal Request
Published April 25, 2013 by PR Web St. Louis, Missouri (PRWEB) April 25, 2013 Pelvic mesh lawyers at Carey Danis & Lowe continue to follow Ethicon MDL 2327 proceedings currently taking place in the U.S. District Court for the Southern District of West Virginia, as the law firm represents women who have been injured by defective pelvic mesh. A recent update in the Ethicon MDL involves a pretrial order issued by Chief Judge Robert C. Chambers and U.S. District Judge Joseph R. Goodwin. The order pertains to the judge responsible for Continue Reading
Pradaxa Timeline: Carey Danis & Lowe Pradaxa Lawyers Chronicle Pradaxa Bleeding Risk
August 15, 2009 – Boehringer Ingelheim researchers submitted Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial data to The New England Journal of Medicine October 19, 2010 – Pradaxa approved by FDA to prevent stroke in patients with atrial fibrillation. December 2011 – FDA announced an investigation into a significant number of reports linking episodes of serious, uncontrollable bleeding with Pradaxa use. November 2012 – FDA released another opinion on the safety of Pradaxa following an FDA evaluation of Pradaxa bleeding events recorded via the FDA’s Sentinel Initiative Mini-Sentinel Continue Reading
Flores v. Ethicon: Transvaginal Mesh Trial Memorandum Opinion & Order
IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF WEST VIRGINIA CHARLESTON DIVISION DAWN FLORES, et al., Plaintiffs, v. CIVIL ACTION NO. 2:12-cv-01804 ETHICON, INC., et al., Defendants. MEMORANDUM OPINION AND ORDER Pending before the court is the plaintiffs’ Motion to Remand [Docket 13]. The plaintiffs also seek sanctions. For the reasons discussed below, the motion to remand and the request for sanctions are DENIED. I. Background This case is one of several thousand assigned to me by the Judicial Panel on Multidistrict Litigation (hereinafter the “MDL Continue Reading
Urologist Testifies in Cooper v. Takeda Actos Lawsuit about Bladder Cancer in California Superior Court
Testimony provided in late March by a urologist in an Actos trial taking place in a Los Angeles court presented an expert’s opinion about the link between Actos and bladder cancer. A urologist, Dr. Norm D. Smith, testified in Cooper v. Takeda Pharmaceuticals America Inc., a case being heard in a California Superior Court. According to Dr. Smith, after examining all of the plaintiff’s health factors, it appeared to him that the cause of the plaintiff’s bladder cancer had a more significant connection to a prolonged use of Actos. Continue Reading
Mirena IUD Lawyers at Carey Danis & Lowe Applaud Federal Mirena IUD Lawsuits Consolidation into MDL
A Judicial Panel on Multidistrict Litigation (JPML) recently ruled that all federal Mirena IUD lawsuits be consolidated into the U.S. District Court for the Southern District of New York. The JPML ordered that Judge Cathy Seibel hear the Mirena MDL proceedings, according to a HarrisMartin Publishing article. Plaintiffs who have cases in the Mirena IUD MDL No. 2434 filed their lawsuits against Bayer citing serious defects with the intrauterine contraceptive device. According to the plaintiffs, Mirena IUD side effects include the device becoming embedded in the uterus, and in Continue Reading
